Miguel Gil‐Gil

Institut d'Investigació Biomédica de Bellvitge

Also affiliated with Institut Català d'Oncologia, Duran i Reynals Hospital, GEICAM – Spanish Breast Cancer Group

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study”.

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2664

N/A

0.689DataRank · unranked

98 citations

Juan Manuel Sepúlveda-Sánchez, Timothy F. Cloughesy, Miguel Gil‐Gil, Vinay K. Puduvalli, Jeffrey J. Raizer +15 more

VAV3 mediates resistance to breast cancer endocrine therapy

UNC Libraries(2020)10.17615/39pm-cr73

N/A

0DataRank · unranked

0 citations

Olle Stål, Miguel Gil‐Gil, Laia Gómez‐Baldó, Xosé R. Bustelo, Xavier Barril +40 more